Understanding/VBG
Rifampicin/NN
Resistance/NN
in/IN
Tuberculosis/NN
through/IN
a/DT
Computational/JJ
Approach/NN
./.
====================
The/DT
disease/NN
tuberculosis/NN
,/,
caused/VBD
by/IN
Mycobacterium/NN
tuberculosis/NN
(/(
MTB/NN
)/)
,/,
remains/VBZ
a/DT
major/JJ
cause/VBP
of/IN
morbidity/NN
and/CC
mortality/NN
in/IN
developing/VBG
countries/NNS
./.
====================
The/DT
evolution/NN
of/IN
drug-resistant/JJ
tuberculosis/NN
causes/VBZ
a/DT
foremost/JJ
threat/NN
to/TO
global/JJ
health/NN
./.
====================
Most/JJS
drug-resistant/JJ
MTB/NN
clinical/JJ
strains/NNS
are/VBP
showing/VBG
resistance/NN
to/TO
isoniazid/JJ
and/CC
rifampicin/NN
(/(
RIF/NN
)/)
,/,
the/DT
frontline/JJ
anti-tuberculosis/NN
drugs/NNS
./.
====================
Mutation/NN
in/IN
rpoB/NN
,/,
the/DT
beta/NN
subunit/NN
of/IN
DNA-directed/JJ
RNA/NN
polymerase/NN
of/IN
MTB/NN
,/,
is/VBZ
reported/VBN
to/TO
be/VB
a/DT
major/JJ
cause/VBP
of/IN
RIF/NN
resistance/NN
./.
====================
Amongst/IN
mutations/NNS
in/IN
the/DT
well-defined/JJ
81-base-pair/JJ
central/JJ
region/NN
of/IN
the/DT
rpoB/NN
gene/NN
,/,
mutation/NN
at/IN
codon/NN
450/CD
(/(
S450L/NN
)/)
and/CC
445/CD
(/(
H445Y/NN
)/)
is/VBZ
mainly/RB
associated/VBN
with/IN
RIF/NN
resistance/NN
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
modeled/VBD
two/CD
resistant/JJ
mutants/NNS
of/IN
rpoB/NN
(/(
S450L/NN
and/CC
H445Y/NN
)/)
using/VBG
Modeller9v10/NN
and/CC
performed/VBN
a/DT
docking/NN
analysis/NN
with/IN
RIF/NN
using/VBG
AutoDock4.2/NN
and/CC
compared/VBD
the/DT
docking/NN
results/NNS
of/IN
these/DT
mutants/NNS
with/IN
the/DT
wild-type/JJ
rpoB/NN
./.
====================
The/DT
docking/NN
results/NNS
revealed/VBD
that/IN
RIF/NN
more/RBR
effectively/RB
inhibited/VBD
the/DT
wild-type/JJ
rpoB/NN
with/IN
low/JJ
binding/NN
energy/NN
than/IN
rpoB/NN
mutants/NNS
./.
====================
The/DT
rpoB/NN
mutants/NNS
interacted/VBD
with/IN
RIF/NN
with/IN
positive/JJ
binding/NN
energy/NN
,/,
revealing/VBG
the/DT
incapableness/NN
of/IN
RIF/NN
inhibition/NN
and/CC
thus/RB
showing/VBG
resistance/NN
./.
====================
Subsequently/RB
,/,
this/DT
was/VBD
verified/VBN
by/IN
molecular/JJ
dynamics/NNS
simulations/NNS
./.
====================
This/DT
in/IN
silico/NN
evidence/NN
may/MD
help/VB
us/PRP
understand/VB
RIF/NN
resistance/NN
in/IN
rpoB/NN
mutant/JJ
strains/NNS
./.
====================
Decades/NNS
after/IN
the/DT
discovery/NN
of/IN
the/DT
Mycobacterium/NN
tuberculosis/NN
(/(
MTB/NN
)/)
organism/NN
,/,
tuberculosis/NN
(/(
TB/NN
)/)
remains/VBZ
a/DT
major/JJ
cause/VBP
of/IN
morbidity/NN
and/CC
mortality/NN
in/IN
several/JJ
developing/VBG
countries/NNS
./.
====================
Nearly/RB
one-third/RB
of/IN
the/DT
world/NN
's/POS
population/NN
is/VBZ
considered/VBN
to/TO
be/VB
infected/JJ
with/IN
MTB/NN
infection/NN
,/,
with/IN
8.6/CD
million/NN
new/JJ
patients/NNS
and/CC
1.3/CD
million/NN
deaths/NNS
in/IN
the/DT
year/NN
2012/CD
,/,
including/VBG
3,20,000/CD
deaths/NNS
among/IN
human/JJ
immunodeficiency/NN
virus-positive/JJ
individuals/NNS
,/,
with/IN
around/IN
2.0-2.4/CD
million/NN
infected/JJ
cases/NNS
of/IN
TB/NN
in/IN
India/FW
alone-i.e./IN
,/,
26/CD
%/NN
of/IN
the/DT
total/JJ
burden/NN
[/(
1/CD
]/)
./.
====================
Multidrug-resistant/JJ
strains/NNS
of/IN
this/DT
pathogen/NN
,/,
emerging/VBG
in/IN
association/NN
with/IN
human/JJ
immunodeficiency/NN
virus/NN
,/,
have/VBP
added/VBN
a/DT
frightening/JJ
dimension/NN
to/TO
the/DT
problem/NN
[/(
2/CD
]/)
./.
====================
Outbreaks/NNS
of/IN
extensively/RB
drug-resistant/JJ
tuberculosis/NN
have/VBP
also/RB
been/VBN
an/DT
increasing/VBG
threat/NN
in/IN
certain/JJ
regions/NNS
around/IN
the/DT
world/NN
[/(
3/CD
]/)
./.
====================
Most/JJS
drug-resistant/JJ
MTB/NN
clinical/JJ
strains/NNS
are/VBP
resistant/JJ
to/TO
the/DT
frontline/JJ
anti-TB/JJ
drugs/NNS
isoniazid/NN
(/(
isonicotinic/JJ
acid/NN
hydrazine/NN
)/)
and/CC
rifampicin/NN
(/(
RIF/NN
)/)
[/(
4/CD
]/)
./.
====================
RIF/NN
belongs/VBZ
to/TO
the/DT
rifamycin/NN
group/NN
and/CC
is/VBZ
a/DT
bactericidal/JJ
antibiotic/JJ
drug/NN
introduced/VBD
in/IN
1963/CD
[/(
5/CD
]/)
./.
====================
It/PRP
inhibits/VBZ
bacterial/JJ
DNA-dependent/JJ
RNA/NN
synthesis/NN
by/IN
inhibiting/VBG
bacterial/JJ
DNA-dependent/JJ
RNA/NN
polymerase/NN
[/(
6/CD
,/,
7/CD
]/)
./.
====================
It/PRP
has/VBZ
a/DT
complex/NN
structure/NN
,/,
having/VBG
a/DT
molecular/JJ
weight/NN
822.95/CD
g/mol/NN
and/CC
containing/VBG
an/DT
aromatic/JJ
nucleus/NN
(/(
Fig/NN
./.
====================
1/CD
)/)
linked/VBN
on/IN
both/CC
sides/NNS
by/IN
an/DT
aliphatic/JJ
bridge/NN
[/(
8/CD
]/)
./.
====================
Due/IN
to/TO
the/DT
lipophilic/JJ
profile/NN
of/IN
the/DT
MTB/NN
cell/NN
membrane/NN
,/,
RIF/NN
diffuses/VBZ
easily/RB
across/IN
it/PRP
[/(
9/CD
]/)
./.
====================
It/PRP
inhibits/VBZ
bacterial/JJ
RNA/NN
synthesis/NN
by/IN
binding/VBG
to/TO
the/DT
Î²/JJ
subunit/NN
of/IN
DNA-dependent/JJ
RNA/NN
polymerase/NN
,/,
thus/RB
blocking/VBG
RNA/NN
transcription/NN
[/(
6/CD
]/)
by/IN
inhibiting/VBG
RNA/NN
chain/NN
initiation/NN
and/CC
elongation/NN
[/(
10/CD
]/)
./.
====================
Even/RB
though/IN
the/DT
molecular/JJ
target/NN
of/IN
RIF/NN
has/VBZ
been/VBN
well/RB
distinguished/VBN
,/,
the/DT
specific/JJ
mechanism/NN
by/IN
which/WDT
it/PRP
interacts/VBZ
with/IN
rpoB/NN
to/TO
lead/VB
to/TO
mycobacterial/JJ
killing/NN
remains/VBZ
unclear/JJ
[/(
8/CD
]/)
./.
====================
RIF/NN
resistance/NN
is/VBZ
mainly/RB
due/JJ
to/TO
mutations/NNS
in/IN
a/DT
well-defined/JJ
,/,
81-base-pair/JJ
central/JJ
region/NN
of/IN
the/DT
rpoB/NN
gene/NN
[/(
11/CD
]/)
./.
====================
More/RBR
than/IN
96/CD
%/NN
of/IN
RIF-resistant/JJ
strains/NNS
contain/VBP
a/DT
mutation/NN
in/IN
this/DT
81-bp/JJ
region/NN
of/IN
rpoB/NN
[/(
12/CD
,/,
13/CD
]/)
./.
====================
The/DT
mutation/NN
that/IN
is/VBZ
most/RBS
frequently/RB
found/VBN
in/IN
clinical/JJ
isolates/NNS
of/IN
MTB/NN
is/VBZ
rpoB/NN
S531L/NN
./.
====================
In/IN
MTB/NN
from/IN
countries/NNS
around/IN
the/DT
world/NN
,/,
rpoB/NN
S450L/NN
(/(
S531L/NN
in/IN
the/DT
case/NN
of/IN
Escherichia/FW
coli/FW
)/)
was/VBD
identified/VBN
in/IN
40/CD
%/NN
-93/CD
%/NN
of/IN
all/DT
RIF/NN
resistance/NN
isolates/NNS
[/(
14,15,16/CD
]/)
.The/DT
single/JJ
amino/NN
acid/NN
mutation/NN
at/IN
codon/NN
445/CD
(/(
i.e./FW
,/,
His/NNP
to/TO
Tyr/NN
[/(
CAC/TAC/NN
]/)
)/)
of/IN
the/DT
rpoB/NN
gene/NN
is/VBZ
also/RB
reported/VBD
to/TO
be/VB
the/DT
most/JJS
widespread/JJ
mutation/NN
,/,
associated/VBN
with/IN
RIF/NN
resistance/NN
[/(
17/CD
]/)
./.
====================
The/DT
rapid/JJ
advances/NNS
in/IN
molecular/JJ
biology/NN
and/CC
the/DT
accessibility/NN
of/IN
new/JJ
information/NN
generated/VBN
after/IN
whole-genome/DT
sequencing/NN
of/IN
MTB/NN
will/MD
be/VB
useful/JJ
in/IN
understanding/VBG
the/DT
mechanism/NN
of/IN
RIF/NN
resistance/NN
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
explored/VBD
the/DT
interaction/NN
of/IN
rpoB/NN
(/(
both/CC
wild/JJ
and/CC
mutant/JJ
proteins/NNS
)/)
with/IN
RIF/NN
through/IN
molecular/JJ
docking/NN
analysis/NN
./.
====================
Hardware/JJ
and/CC
software/JJ
====================
The/DT
study/NN
was/VBD
carried/VBN
out/RP
on/IN
a/DT
Dell/JJ
Workstation/NN
with/IN
a/DT
2.26/CD
GHz/NN
processor/NN
,/,
6/CD
GB/NN
RAM/NN
,/,
and/CC
500/CD
GB/NN
HDD/NN
running/VBG
in/IN
the/DT
Windows/NNS
operating/VBG
system/NN
./.
====================
Bioinformatics/NNS
software/JJ
,/,
such/JJ
as/IN
AutoDock4.2/NN
,/,
and/CC
online/JJ
resources/VBZ
were/VBD
used/VBN
./.
====================
MTB/NN
rpoB/NN
protein/NN
====================
DNA-directed/JJ
RNA/NN
polymerase/NN
beta/NN
chain/NN
(/(
rpoB/NN
)/)
,/,
encoded/VBN
by/IN
Rv0667/NN
of/IN
MTB/NN
,/,
is/VBZ
reported/VBN
to/TO
be/VB
directly/RB
involved/VBN
in/IN
RIF/NN
resistance/NN
./.
====================
The/DT
rpoB/NN
protein/NN
sequence/NN
was/VBD
retrieved/VBN
from/IN
NCBI/NN
(/(
http/NN
:/:
//www.ncbi.nlm.nih.gov//JJ
)/)
./.
====================
Protein/NN
structure/NN
prediction/NN
and/CC
validation/NN
of/IN
rpoB/NN
====================
Protein/NN
Homology/Analogy/NN
Recognition/NN
Engine/NN
(/(
Phyre2/NN
)/)
server/RB
[/(
18/CD
]/)
was/VBD
used/VBN
for/IN
modeling/VBG
the/DT
three-dimensional/JJ
structure/NN
of/IN
rpoB/NN
./.
====================
Phyre2/NN
is/VBZ
an/DT
automatic/JJ
fold/JJ
recognition/NN
server/RB
that/DT
predicts/VBZ
the/DT
three-dimensional/JJ
structure/NN
of/IN
a/DT
protein/NN
sequence/NN
using/VBG
the/DT
principles/NNS
and/CC
techniques/NNS
of/IN
homology/NN
modeling/VBG
./.
====================
The/DT
Phyre/JJ
is/VBZ
widely/RB
used/VBN
by/IN
the/DT
biological/JJ
community/NN
,/,
with/IN
more/RBR
than/IN
150/CD
submissions/NNS
per/FW
day/NN
[/(
18/CD
]/)
./.
====================
The/DT
Phyre2/NN
server/RB
was/VBD
publicly/RB
released/VBN
in/IN
February/JJ
2011/CD
as/IN
a/DT
replacement/JJ
for/IN
the/DT
original/JJ
Phyre/NN
server/RB
and/CC
provides/VBZ
extra/JJ
functionality/NN
over/IN
Phyre/JJ
,/,
a/DT
more/RBR
advanced/JJ
interface/NN
,/,
and/CC
a/DT
fully/RB
updated/VBN
fold/JJ
library/NN
and/CC
uses/VBZ
the/DT
HHpred/HHsearch/NN
package/NN
for/IN
homology/NN
detection/NN
./.
====================
Two/CD
mutants/NNS
of/IN
rpoB/NN
(/(
S450L/NN
and/CC
H445Y/NN
)/)
were/VBD
generated/VBN
using/VBG
Modeller9v10/NN
[/(
19/CD
]/)
./.
====================
Structural/JJ
refinement/JJ
and/CC
energy/NN
minimization/NN
of/IN
the/DT
predicted/VBN
models/NNS
were/VBD
carried/VBN
out/RP
using/VBG
the/DT
Yet/RB
Another/DT
Scientific/JJ
Artificial/JJ
Reality/NN
Application/NN
(/(
YASARA/NN
)/)
Energy/NN
Minimization/NN
Server/NN
[/(
20/CD
]/)
./.
====================
The/DT
refined/VBN
model/NN
reliability/NN
was/VBD
assessed/VBN
through/IN
Procheck/NN
[/(
21/CD
]/)
,/,
ProSA-web/NN
[/(
22/CD
]/)
,/,
and/CC
ProQ/NN
[/(
23/CD
]/)
./.
====================
Ligand/NN
preparation/NN
====================
The/DT
ligand/NN
RIF/NN
used/VBN
in/IN
this/DT
study/NN
against/IN
rpoB/NN
was/VBD
retrieved/VBN
from/IN
the/DT
PubChem/JJ
database/NN
[/(
24/CD
]/)
in/IN
mol2/NN
format/IN
,/,
and/CC
the/DT
PyMol/NN
molecular/JJ
graphics/NNS
system/NN
(/(
http/NN
:/:
//www.pymol.org/JJ
)/)
was/VBD
used/VBN
to/TO
convert/VB
it/PRP
into/IN
PDB/NN
format/IN
./.
====================
Protein-ligand/CC
docking/NN
====================
Protein-ligand/CC
docking/NN
studies/NNS
were/VBD
performed/VBN
using/VBG
the/DT
AutoDock/NN
4.2/CD
program/NN
[/(
25/CD
]/)
./.
====================
It/PRP
is/VBZ
one/CD
of/IN
the/DT
most/JJS
widely/RB
used/VBN
methods/NNS
for/IN
protein-ligand/NN
docking/NN
./.
====================
All/DT
pre-processing/VBG
steps/NNS
for/IN
the/DT
ligand/NN
and/CC
protein/NN
files/NNS
were/VBD
performed/VBN
using/VBG
the/DT
AutoDock/NN
Tools/NNS
1.5.4/CD
program/NN
(/(
ADT/NN
)/)
,/,
which/WDT
has/VBZ
been/VBN
released/VBN
as/IN
an/DT
extension/NN
suite/JJ
to/TO
Python/NN
Molecular/JJ
Viewer/JJR
[/(
25/CD
]/)
./.
====================
The/DT
ADT/NN
program/NN
was/VBD
used/VBN
to/TO
prepare/VB
the/DT
receptor/NN
molecule/NN
(/(
rpoB/NN
)/)
by/IN
adding/VBG
all/DT
hydrogen/NN
atoms/NNS
to/TO
the/DT
receptor/NN
,/,
and/CC
Kollman/JJ
charges/NNS
were/VBD
also/RB
assigned/VBD
./.
====================
For/IN
docked/VBD
ligands/NNS
,/,
non-polar/JJ
hydrogens/NNS
were/VBD
also/RB
added/VBN
./.
====================
Gasteiger/RBR
charges/NNS
were/VBD
assigned/VBN
,/,
and/CC
torsional/JJ
degrees/NNS
of/IN
freedom/JJ
were/VBD
allocated/VBN
by/IN
the/DT
ADT/NN
program/NN
./.
====================
The/DT
Lamarckian/JJ
genetic/JJ
algorithm/NN
(/(
LGA/NN
)/)
was/VBD
applied/VBN
to/TO
model/VB
the/DT
interaction/NN
pattern/NN
between/IN
the/DT
receptor/NN
and/CC
ligand/NN
./.
====================
The/DT
grid/JJ
maps/VBZ
representing/VBG
the/DT
receptor/NN
proteins/NNS
in/IN
the/DT
docking/NN
process/NN
were/VBD
calculated/VBN
using/VBG
AutoGrid/JJ
(/(
part/NN
of/IN
the/DT
AutoDock/NN
package/NN
)/)
./.
====================
A/DT
grid/JJ
of/IN
50/CD
,/,
50/CD
,/,
and/CC
50/CD
points/NNS
in/IN
the/DT
x/NN
,/,
y/RB
,/,
and/CC
z/NN
directions/NNS
was/VBD
centered/JJ
on/IN
the/DT
known/JJ
active/JJ
site/NN
residues/NNS
of/IN
rpoB/NN
protein/NN
./.
====================
For/IN
all/DT
docking/NN
procedures/NNS
,/,
10/CD
independent/JJ
genetic/JJ
algorithm/NN
runs/NNS
with/IN
a/DT
population/NN
size/NN
of/IN
150/CD
were/VBD
considered/VBN
for/IN
each/DT
molecule/NN
under/IN
study/NN
./.
====================
A/DT
maximum/JJ
number/NN
of/IN
25/CD
Ã/NN
105/CD
energy/NN
evaluations/NNS
;/:
27,000/CD
maximum/NN
generations/NNS
;/:
a/DT
gene/NN
mutation/NN
rate/NN
of/IN
0.02/CD
,/,
and/CC
a/DT
crossover/JJ
rate/NN
of/IN
0.8/CD
were/VBD
used/VBN
for/IN
the/DT
LGA/NN
./.
====================
The/DT
AutoDock/NN
program/NN
was/VBD
run/JJ
in/IN
order/NN
to/TO
prepare/VB
the/DT
corresponding/JJ
docking/NN
log/NN
(/(
DLG/NN
)/)
file/JJ
for/IN
further/JJ
analysis/NN
./.
====================
Molecular/JJ
dynamic/JJ
simulations/NNS
of/IN
the/DT
rpoB-RIF/NN
complex/NN
====================
The/DT
docking/NN
complexes/NNS
of/IN
RIF/NN
with/IN
wild/JJ
and/CC
mutant/JJ
(/(
S450L/NN
)/)
rpoB/NN
were/VBD
subjected/VBN
to/TO
molecular/JJ
dynamic/JJ
(/(
MD/NN
)/)
simulation/JJ
using/VBG
the/DT
GROMACS/NN
4.6.3/CD
[/(
26/CD
]/)
simulation/JJ
packages/NNS
,/,
employing/VBG
the/DT
gromos54A7/NN
all-atom/IN
force/IN
field/NN
,/,
as/IN
this/DT
particular/JJ
mutant/JJ
has/VBZ
more/RBR
impact/NN
on/IN
drug/NN
resistance/NN
than/IN
H445Y/NN
./.
====================
The/DT
protein/NN
was/VBD
protonated/VBN
at/IN
default/NN
pH/NN
,/,
and/CC
the/DT
ligand/NN
topology/NN
was/VBD
generated/VBN
by/IN
the/DT
PRODRG/NN
server/RB
[/(
27/CD
]/)
./.
====================
Then/RB
,/,
the/DT
complexes/NNS
were/VBD
solvated/VBN
by/IN
explicit/NN
SPC/E/NN
(/(
extended/VBD
simple/JJ
point/NN
charge/NN
)/)
water/NN
model/NN
[/(
28/CD
]/)
in/IN
cubic/JJ
boxes/NNS
with/IN
a/DT
minimum/JJ
edge/NN
distance/NN
of/IN
7/CD
Ã/NNP
from/IN
the/DT
box/NN
./.
====================
Both/DT
systems/NNS
were/VBD
neutralized/VBN
electrically/RB
by/IN
adding/VBG
0.10/CD
mM/NN
NaCl/NN
./.
====================
Both/DT
systems/NNS
had/VBD
been/VBN
relaxed/VBN
through/IN
steepest/JJ
descent/JJ
energy/NN
minimization/NN
,/,
followed/VBN
by/IN
temperature/NN
(/(
NVT-constant/JJ
number/NN
of/IN
particles/NNS
,/,
volume/NN
and/CC
temperature/NN
)/)
and/CC
pressure/NN
(/(
NPT-constant/JJ
number/NN
of/IN
particles/NNS
,/,
pressure/NN
and/CC
temperature/NN
)/)
equilibrium/NN
for/IN
100/CD
ps/NNS
each/DT
./.
====================
The/DT
NVT/NN
was/VBD
performed/VBN
at/IN
300/CD
K/NN
with/IN
position/NN
restraints/NNS
applied/VBN
to/TO
all/DT
of/IN
the/DT
backbone/NN
atoms/NNS
,/,
and/CC
during/IN
NPT/NN
,/,
all/DT
of/IN
these/DT
restraints/NNS
were/VBD
removed/VBN
./.
====================
All/DT
bond/NN
lengths/NNS
were/VBD
constrained/VBN
using/VBG
the/DT
linear/JJ
constraint/NN
solver/RB
(/(
LINCS/NN
)/)
algorithm/NN
[/(
29/CD
]/)
./.
====================
For/IN
the/DT
temperature/NN
and/CC
pressure/NN
coupling/NN
,/,
the/DT
velocity/NN
rescale/JJ
thermostat/DT
[/(
30/CD
]/)
and/CC
isotropic/JJ
Parrinello-Rahman/JJ
barostat/NN
[/(
31/CD
]/)
were/VBD
applied/VBN
,/,
respectively/RB
./.
====================
For/IN
the/DT
calculation/NN
of/IN
long-range/JJ
electrostatic/JJ
interactions/NNS
,/,
Particle/NN
Mesh/JJ
Ewald/JJ
(/(
PME/NN
)/)
was/VBD
used/VBN
with/IN
a/DT
fourth-order/JJ
spline/NN
interpolation/NN
and/CC
0.15-nm/CD
Fourier/CD
grid/JJ
spacing/NN
[/(
32/CD
]/)
./.
====================
The/DT
short-range/JJ
non-bonded/JJ
van/NN
der/NN
Waals/NNS
and/CC
Coulombic/JJ
interactions/NNS
were/VBD
considered/VBN
between/IN
particles/NNS
within/IN
12/CD
Ã/NN
of/IN
cutoff/JJ
distance/NN
./.
====================
During/IN
the/DT
production/NN
run/RB
,/,
all/DT
of/IN
these/DT
protocols/NNS
were/VBD
followed/VBN
along/IN
with/IN
the/DT
temperature/NN
coupling/NN
at/IN
323/CD
K/NN
using/VBG
the/DT
velocity/NN
rescale/JJ
thermostat/DT
with/IN
a/DT
coupling/NN
time/NN
constant/JJ
of/IN
(/(
ÏT/JJ
)/)
of/IN
0.8/CD
ps/NNS
and/CC
pressure/NN
coupling/VBG
by/IN
the/DT
Parrinello-Rahman/JJ
barostat/JJ
at/IN
1/CD
bar/JJ
,/,
via/IN
a/DT
coupling/NN
constant/JJ
of/IN
ÏP/JJ
=/JJ
2/CD
ps/NNS
with/IN
compressibility/NN
at/IN
0.000045/bar/JJ
./.
====================
Snapshots/NNS
of/IN
the/DT
trajectory/JJ
were/VBD
taken/VBN
every/RB
2/CD
ps/NNS
,/,
and/CC
the/DT
Microsoft/NN
Excel/JJ
program/NN
was/VBD
used/VBN
for/IN
preparation/NN
of/IN
the/DT
graph/NN
./.
====================
Visualization/NN
====================
The/DT
visualization/NN
of/IN
the/DT
structure/NN
files/NNS
was/VBD
done/VBN
using/VBG
the/DT
graphical/JJ
interface/NN
of/IN
the/DT
ADT/NN
tool/NN
and/CC
the/DT
PyMol/NN
molecular/JJ
graphics/NNS
system/NN
(/(
http/NN
:/:
//www.pymol.org/JJ
)/)
./.
====================
RpoB/NN
of/IN
MTB/NN
,/,
encoded/VBN
by/IN
Rv0667/NN
,/,
has/VBZ
1172/CD
amino/NN
acids/NNS
in/IN
its/PRP$
protein/NN
sequence/NN
,/,
while/IN
E./FW
coli/FW
rpoB/NN
has/VBZ
1342/CD
./.
====================
The/DT
S531L/NN
and/CC
H526Y/NN
mutations/NNS
are/VBP
based/VBN
on/IN
the/DT
protein/NN
sequence/NN
of/IN
E./FW
coli/FW
rpoB/NN
protein/NN
./.
====================
Upon/IN
sequence/NN
comparison/NN
using/VBG
ClustalW/NN
[/(
33/CD
]/)
of/IN
rpoB/NN
protein/NN
in/IN
both/DT
species/NNS
,/,
it/PRP
was/VBD
found/VBN
that/IN
in/IN
MTB/NN
,/,
the/DT
mutation/NN
occurred/VBD
at/IN
codon/NN
positions/NNS
450/CD
(/(
S450L/NN
)/)
and/CC
445/CD
(/(
H445Y/NN
)/)
as/IN
compared/VBN
to/TO
E./FW
coli/FW
(/(
Fig/NN
./.
====================
2/CD
)/)
./.
====================
Validation/NN
of/IN
model/NN
====================
Since/IN
the/DT
three-dimensional/JJ
structure/NN
of/IN
rpoB/NN
of/IN
MTB/NN
was/VBD
still/RB
not/RB
available/JJ
,/,
its/PRP$
structure/NN
model/NN
was/VBD
predicted/VBN
using/VBG
the/DT
Phyre2/NN
server/RB
by/IN
taking/VBG
chain/NN
C/NN
of/IN
DNA-directed/JJ
RNA/NN
polymerase/NN
subunit/NN
beta/NN
from/IN
E./FW
coli/FW
(/(
PDB/NN
ID/NN
,/,
3LU0/CD
)/)
[/(
34/CD
]/)
as/IN
the/DT
structural/JJ
template/NN
./.
====================
The/DT
query/RB
coverage/NN
of/IN
the/DT
target-template/NN
alignment/NN
was/VBD
91/CD
%/NN
with/IN
100.0/CD
%/NN
confidence/NN
by/IN
the/DT
single/JJ
highest-scoring/JJ
template/NN
./.
====================
The/DT
predicted/VBN
structure/NN
was/VBD
then/RB
subjected/VBD
to/TO
the/DT
YASARA/NN
Energy/NN
Minimization/NN
Server/NN
for/IN
structural/JJ
refinement/JJ
./.
====================
The/DT
total/JJ
energy/NN
for/IN
the/DT
refined/VBN
structure/NN
obtained/VBN
from/IN
the/DT
YASARA/NN
Energy/NN
Minimization/NN
Server/NN
was/VBD
-130,601.7/CD
kcal/mol/NN
(/(
score/RB
,/,
-2.60/CD
)/)
,/,
whereas/IN
prior/JJ
to/TO
energy/NN
minimization/NN
,/,
it/PRP
was/VBD
359,868,668,000.6/CD
kcal/mol/NN
(/(
score/RB
,/,
-4.20/CD
)/)
./.
====================
The/DT
stereochemistry/NN
of/IN
the/DT
refined/VBN
model/NN
(/(
Procheck/NN
analysis/NN
)/)
revealed/VBD
that/IN
87.1/CD
%/NN
of/IN
residues/NNS
were/VBD
situated/VBN
in/IN
the/DT
most/JJS
favorable/JJ
region/NN
,/,
and/CC
12.3/CD
%/NN
was/VBD
in/IN
additional/JJ
and/CC
generously/RB
allowed/VBD
regions/NNS
,/,
whereas/IN
only/RB
0.5/CD
%/NN
of/IN
residues/NNS
fell/JJ
in/IN
the/DT
disallowed/JJ
region/NN
of/IN
the/DT
Ramachandran/NN
plot/NN
(/(
Fig/NN
./.
====================
3A/NN
)/)
./.
====================
The/DT
ProSA-web/NN
evaluation/NN
revealed/VBD
a/DT
compatible/JJ
Z/NN
score/NN
(/(
Fig/NN
./.
====================
3D/RB
)/)
value/NN
of/IN
-12.3/CD
,/,
which/WDT
is/VBZ
well/RB
within/IN
the/DT
range/NN
of/IN
native/JJ
conformations/NNS
of/IN
crystal/JJ
structures/NNS
[/(
22/CD
]/)
./.
====================
The/DT
overall/JJ
residue/NN
energies/VBZ
of/IN
the/DT
rpoB/NN
3D/NN
model/NN
were/VBD
largely/RB
negative/JJ
,/,
except/IN
for/IN
a/DT
few/JJ
peaks/NNS
./.
====================
The/DT
3D/NN
model/NN
of/IN
rpoB/NN
showed/VBD
a/DT
Levitt-Gerstein/JJ
(/(
LG/NN
)/)
score/RB
of/IN
4.065/CD
by/IN
the/DT
Protein/NN
Quality/NN
Predictor/NN
(/(
ProQ/NN
)/)
tool/NN
,/,
implying/VBG
a/DT
high/JJ
accuracy/NN
level/NN
of/IN
the/DT
predicted/VBN
structure/NN
./.
====================
A/DT
ProQ/NN
LG/NN
score/RB
>/JJR
4.0/CD
is/VBZ
necessary/JJ
for/IN
suggesting/VBG
that/IN
a/DT
model/NN
has/VBZ
extremely/RB
good/JJ
quality/NN
[/(
23/CD
]/)
./.
====================
The/DT
single/JJ
amino/NN
acid/NN
mutation/NN
at/IN
codon/NN
450/CD
(/(
i.e./FW
,/,
Ser/NN
to/TO
Leu/NNP
[/(
TCG/NN
to/TO
TTG/NN
]/)
)/)
and/CC
at/IN
codon/NN
445/CD
(/(
i.e./FW
,/,
His/NNP
to/TO
Tyr/NN
[/(
CAC/TAC/NN
]/)
)/)
of/IN
the/DT
rpoB/NN
gene/NN
is/VBZ
reported/VBN
to/TO
be/VB
the/DT
most/JJS
widespread/JJ
mutation/NN
,/,
associated/VBN
with/IN
RIF/NN
resistance/NN
[/(
17/CD
]/)
./.
====================
Thus/RB
,/,
mutant/JJ
models/NNS
of/IN
rpoB/NN
(/(
S450L/NN
and/CC
H445Y/NN
)/)
were/VBD
generated/VBN
and/CC
subjected/VBD
to/TO
validation/NN
./.
====================
The/DT
stereochemistry/NN
of/IN
the/DT
rpoB/NN
(/(
S450L/NN
)/)
model/NN
(/(
Procheck/NN
analysis/NN
)/)
revealed/VBD
that/IN
89.3/CD
%/NN
of/IN
residues/NNS
were/VBD
situated/VBN
in/IN
the/DT
most/JJS
favorable/JJ
region/NN
,/,
and/CC
9.9/CD
%/NN
was/VBD
in/IN
additional/JJ
allowed/VBD
and/CC
generously/RB
allowed/VBD
regions/NNS
,/,
whereas/IN
only/RB
0.8/CD
%/NN
of/IN
residues/NNS
fell/JJ
in/IN
the/DT
disallowed/JJ
region/NN
of/IN
the/DT
Ramachandran/NN
plot/NN
(/(
Fig/NN
./.
====================
3B/NN
)/)
./.
====================
In/IN
the/DT
case/NN
of/IN
the/DT
rpoB/NN
(/(
H445Y/NN
)/)
model/NN
,/,
87.5/CD
%/NN
of/IN
residues/NNS
were/VBD
found/VBN
in/IN
the/DT
most/JJS
favorable/JJ
region/NN
,/,
and/CC
11.6/CD
%/NN
was/VBD
in/IN
additional/JJ
and/CC
generously/RB
allowed/VBD
regions/NNS
;/:
only/RB
0.9/CD
%/NN
of/IN
residues/NNS
fell/JJ
in/IN
the/DT
disallowed/JJ
region/NN
(/(
Fig/NN
./.
====================
3C/NN
)/)
./.
====================
The/DT
ProSA-web/NN
evaluation/NN
revealed/VBD
a/DT
compatible/JJ
Z/NN
score/RB
value/NN
of/IN
around/IN
-12.1/CD
for/IN
both/DT
rpoB/NN
mutant/JJ
models/NNS
(/(
i.e./FW
,/,
S450L/NN
and/CC
H445Y/NN
)/)
(/(
Fig/NN
./.
====================
3E/DT
and/CC
3F/NN
)/)
,/,
which/WDT
is/VBZ
well/RB
within/IN
the/DT
range/NN
of/IN
native/JJ
conformations/NNS
of/IN
crystal/JJ
structures/NNS
[/(
22/CD
]/)
./.
====================
The/DT
overall/JJ
residue/NN
energies/VBZ
of/IN
the/DT
rpoB/NN
3D/NN
model/NN
were/VBD
largely/RB
negative/JJ
,/,
expect/VBP
for/IN
a/DT
few/JJ
peaks/NNS
./.
====================
The/DT
3D/NN
model/NN
of/IN
both/DT
mutants/NNS
showed/VBD
an/DT
LG/NN
score/RB
of/IN
more/RBR
than/IN
4.1/CD
by/IN
the/DT
ProQ/NN
tool/NN
,/,
implying/VBG
a/DT
high/JJ
accuracy/NN
level/NN
of/IN
the/DT
predicted/VBN
structure/NN
./.
====================
A/DT
ProQ/NN
LG/NN
score/RB
>/JJR
4/CD
is/VBZ
necessary/JJ
for/IN
suggesting/VBG
that/IN
a/DT
model/NN
has/VBZ
extremely/RB
good/JJ
quality/NN
[/(
23/CD
]/)
./.
====================
Docking/VBG
analysis/NN
of/IN
rpoB/NN
and/CC
RIF/NN
====================
On/IN
the/DT
basis/NN
of/IN
the/DT
modeled/JJ
structure/NN
of/IN
rpoB/NN
(/(
Fig/NN
./.
====================
4A/CD
)/)
,/,
three-dimensional/JJ
structures/NNS
of/IN
the/DT
two/CD
mutants/NNS
were/VBD
obtained/VBN
./.
====================
The/DT
protein/NN
(/(
rpoBs/NNS
)/)
-ligand/JJ
(/(
RIF/NN
)/)
analysis/NN
was/VBD
performed/VBN
using/VBG
AutoDock4.2/NN
software/JJ
[/(
25/CD
]/)
./.
====================
Out/DT
of/IN
the/DT
10/CD
poses/VBZ
obtained/VBN
,/,
the/DT
best/JJS
ligand/NN
pose/JJ
was/VBD
selected/VBN
based/VBN
on/IN
the/DT
lowest/JJS
binding/NN
energy/NN
confirmation/NN
./.
====================
As/IN
the/DT
amino/NN
acid/NN
(/(
serine/NN
at/IN
450/CD
and/CC
histidine/NN
at/IN
445/CD
)/)
position/NN
of/IN
rpoB/NN
was/VBD
reported/VBN
to/TO
undergo/VB
mutation/NN
in/IN
most/JJS
of/IN
the/DT
RIF/NN
resistance/NN
strains/NNS
,/,
the/DT
docking/NN
of/IN
RIF/NN
was/VBD
performed/VBN
around/IN
these/DT
amino/NN
acid/NN
positions/NNS
./.
====================
Upon/IN
docking/NN
,/,
RIF/NN
interacts/VBZ
with/IN
the/DT
wild-type/JJ
rpoB/NN
protein/NN
(/(
Fig/NN
./.
====================
4B/NN
)/)
with/IN
a/DT
binding/VBG
energy/NN
of/IN
-4.96/CD
kcal/mol/NN
and/CC
inhibition/NN
constant/JJ
of/IN
231.21/CD
ÂµM/NN
,/,
whereas/IN
in/IN
the/DT
case/NN
of/IN
the/DT
rpoB/NN
(/(
S450L/NN
)/)
and/CC
rpoB/NN
(/(
H445Y/NN
)/)
mutants/NNS
,/,
the/DT
binding/VBG
energies/VBZ
were/VBD
found/VBN
to/TO
be/VB
8.38/CD
kcal/mol/NN
and/CC
3.91/CD
kcal/mol/NN
,/,
respectively/RB
,/,
with/IN
no/DT
inhibition/NN
constants/NNS
predicted/VBN
,/,
which/WDT
revealed/VBD
RIF/NN
resistance/NN
in/IN
the/DT
mutant/JJ
proteins/NNS
./.
====================
MD/NN
simulation/NN
studies/NNS
of/IN
the/DT
rpoB/NN
and/CC
RIF/NN
complex/NN
====================
A/DT
ligand/NN
binding/NN
interaction/NN
always/RB
influences/VBZ
the/DT
stability/NN
of/IN
the/DT
receptor/NN
protein/NN
./.
====================
It/PRP
was/VBD
shown/VBN
in/IN
Fig/NN
./.
====================
5A/DT
that/DT
the/DT
Root/NN
Mean/JJ
Square/NN
Deviation/NN
(/(
RMSD/NN
)/)
graph/NN
of/IN
wild-type/JJ
rpoB/NN
lies/VBZ
a/DT
bit/NN
down/RB
than/IN
the/DT
S450L/NN
mutant/JJ
during/IN
most/JJS
of/IN
the/DT
time/NN
scale/NN
./.
====================
The/DT
same/JJ
was/VBD
also/RB
observed/VBN
in/IN
the/DT
Root/NN
Mean/JJ
Square/NN
Fluctuation/NN
(/(
RMSF/NN
)/)
plot/NN
(/(
Fig/NN
./.
====================
5D/CD
)/)
,/,
where/WRB
most/JJS
interacting/VBG
amino/NN
acids/NNS
of/IN
wild-type/JJ
rpoB/NN
that/DT
participate/VBP
in/IN
the/DT
interaction/NN
with/IN
RIF/NN
fluctuate/NN
less/RBR
comparatively/RB
./.
====================
This/DT
justifies/VBZ
that/DT
the/DT
sustainability/NN
of/IN
the/DT
rpoB-RIF/NN
interaction/NN
and/CC
wild-type/JJ
rpoB/NN
is/VBZ
more/RBR
acceptable/JJ
over/IN
the/DT
mutant/JJ
./.
====================
We/PRP
also/RB
calculated/VBN
the/DT
average/NN
number/NN
of/IN
hydrogen/NN
bonds/NNS
and/CC
their/PRP$
occurrence/NN
between/IN
the/DT
receptor/NN
and/CC
ligand/NN
in/IN
both/DT
cases/NNS
and/CC
found/VBD
that/IN
in/IN
the/DT
case/NN
of/IN
wild-type/JJ
rpoB/NN
,/,
the/DT
protein/NN
formed/VBD
more/RBR
consistent/JJ
numbers/NNS
of/IN
H-bonds/NNS
with/IN
the/DT
ligand/NN
(/(
Fig/NN
./.
====================
5B/NN
)/)
as/IN
a/DT
consequence/NN
of/IN
a/DT
good/JJ
interaction/NN
./.
====================
Most/JJS
importantly/RB
,/,
these/DT
bindings/NNS
were/VBD
also/RB
described/VBN
via/IN
interaction/NN
energies/VBZ
(/(
IEs/NNS
)/)
./.
====================
The/DT
sum/NN
of/IN
short-range/JJ
Coulombic/JJ
and/CC
van/NN
der/NN
Waals/NNS
interaction/NN
energies/VBZ
,/,
taken/VBN
as/IN
the/DT
total/JJ
interaction/NN
energy/NN
between/IN
the/DT
protein/NN
and/CC
ligand/NN
,/,
was/VBD
plotted/VBN
in/IN
Fig/NN
./.
====================
5C/NN
./.
====================
This/DT
plot/NN
clearly/RB
indicates/VBZ
a/DT
big/NN
difference/NN
in/IN
IEs/NNS
between/IN
the/DT
two/CD
complexes/NNS
,/,
and/CC
the/DT
wild-type/JJ
rpoB/NN
possesses/VBZ
comparatively/RB
less/RBR
interaction/NN
energy/NN
and/CC
hence/RB
shows/VBZ
more/RBR
affinity/NN
towards/IN
RIF/NN
./.
====================
Brandis/DT
and/CC
Hughes/NNS
[/(
15/CD
]/)
created/VBD
the/DT
rpoB/NN
S531L/NN
mutation/NN
in/IN
Salmonella/FW
which/WDT
is/VBZ
also/RB
present/JJ
in/IN
other/JJ
location/NN
of/IN
MTB/NN
and/CC
demonstrated/VBD
that/IN
the/DT
minimum/JJ
inhibitory/JJ
concentration/NN
value/NN
of/IN
RIF/NN
for/IN
rpoB/NN
S531L/NN
mutant/JJ
was/VBD
3,000/CD
mg/L/NN
,/,
whereas/IN
for/IN
the/DT
wild-type/JJ
,/,
it/PRP
was/VBD
only/RB
12/CD
mg/L/NN
[/(
15/CD
]/)
./.
====================
This/DT
correlates/VBZ
with/IN
our/PRP$
in/IN
silico/NN
docking/NN
and/CC
MD/NN
simulation/JJ
study-that/IN
mutant/JJ
proteins/NNS
with/IN
positive/JJ
binding/NN
energy/NN
bind/VBP
ineffectively/RB
with/IN
RIF/NN
compared/VBN
to/TO
wild-type/JJ
protein/NN
and/CC
thus/RB
may/MD
require/VB
high/JJ
concentrations/NNS
of/IN
RIF/NN
for/IN
inhibition/NN
./.
====================
We/PRP
have/VBP
employed/VBN
a/DT
computational/JJ
approach/NN
to/TO
study/VB
the/DT
interaction/NN
between/IN
RIF/NN
and/CC
rpoB/NN
and/CC
its/PRP$
mutant/JJ
models/NNS
./.
====================
Our/PRP$
in/IN
silico/NN
docking/NN
study/NN
revealed/VBD
that/IN
mutation/NN
in/IN
rpoB/NN
at/IN
amino/NN
acid/NN
positions/NNS
450/CD
(/(
S450L/NN
)/)
and/CC
445/CD
(/(
H445Y/NN
)/)
might/MD
be/VB
involved/VBN
in/IN
drug/NN
resistance/NN
./.
====================
In/IN
wild-type/JJ
rpoB/NN
,/,
the/DT
RIF/NN
binds/VBZ
more/RBR
effectively/RB
with/IN
rpoB/NN
with/IN
low/JJ
binding/NN
energy/NN
and/CC
thus/RB
inhibits/VBZ
rpoB/NN
protein/NN
./.
====================
Other/JJ
mutations/NNS
in/IN
rpoB/NN
need/VBD
to/TO
be/VB
explored/VBN
further/RBR
for/IN
understanding/VBG
the/DT
resistance/NN
mechanism/NN
./.
====================
Chemical/JJ
structure/NN
of/IN
rifampicin/NN
(/(
formula/FW
,/,
C43H58N4O12/NN
;/:
molecular/JJ
weight/NN
,/,
822.95/CD
g/mol/NN
)/)
./.
====================
Sequence/NN
alignment/NN
of/IN
rpoB/NN
protein/NN
of/IN
Escherichia/FW
coli/FW
and/CC
Mycobacterium/NN
tuberculosis/NN
(/(
MTB/NN
)/)
with/IN
the/DT
respective/JJ
codon/NN
position/NN
and/CC
reported/VBD
amino/NN
acid/NN
substitution/NN
./.
====================
(/(
A/NN
)/)
Ramachandran/NN
plot/NN
of/IN
predicted/VBN
rpoB/NN
model/NN
./.
====================
(/(
B/NN
)/)
Ramachandran/NN
plot/NN
of/IN
predicted/VBN
rpoB/NN
(/(
S450L/NN
)/)
./.
====================
(/(
C/NN
)/)
Ramachandran/NN
plot/NN
of/IN
predicted/VBN
rpoB/NN
(/(
H445Y/NN
)/)
mutant/JJ
models/NNS
./.
====================
(/(
D/NN
)/)
Zplot/NN
of/IN
rpoB/NN
./.
====================
(/(
E/NN
)/)
Zplot/NN
of/IN
rpoB/NN
(/(
S450L/NN
)/)
model/NN
./.
====================
(/(
F/NN
)/)
Zplot/NN
of/IN
rpoB/NN
(/(
H445Y/NN
)/)
./.
====================
ProSA-web/NN
Z-scores/NNS
of/IN
all/DT
protein/NN
chains/NNS
in/IN
PDB/NN
,/,
determined/VBN
by/IN
X-ray/NN
crystallography/NN
and/CC
nuclear/JJ
magnetic/JJ
resonance/NN
(/(
NMR/NN
)/)
spectroscopy/NN
,/,
with/IN
respect/NN
to/TO
their/PRP$
length/NN
./.
====================
The/DT
Z-score/JJ
of/IN
rpoB/NN
and/CC
its/PRP$
mutants/NNS
were/VBD
present/JJ
in/IN
that/DT
range/NN
,/,
represented/VBN
as/IN
black/JJ
dots/NNS
./.
====================
(/(
A/NN
)/)
3D/NN
structure/NN
of/IN
predicted/VBN
rpoB/NN
model/NN
./.
====================
(/(
B/NN
)/)
Docking/VBG
interaction/NN
of/IN
rifampicin/NN
with/IN
rpoB/NN
enzyme/NN
(/(
with/IN
binding/VBG
energy/NN
of/IN
-4.96/CD
kcal/mol/NN
)/)
,/,
showing/VBG
hydrogen/NN
bonds/NNS
as/IN
dotted/VBN
lines/NNS
./.
====================
(/(
A/NN
)/)
Root/NN
Mean/JJ
Square/NN
Deviation/NN
plot/NN
of/IN
rpoB/NN
wild-type/JJ
and/CC
S450L/NN
mutant/JJ
./.
====================
(/(
B/NN
)/)
Occurrence/NN
of/IN
hydrogen/NN
bonds/NNS
between/IN
rpoB/NN
and/CC
rifampicin/NN
(/(
RIF/NN
)/)
throughout/IN
the/DT
simulation/JJ
with/IN
standard/JJ
deviation/NN
./.
====================
(/(
C/NN
)/)
Interaction/NN
energy/NN
profile/NN
between/IN
rpoB/NN
and/CC
RIF/NN
./.
====================
(/(
D/NN
)/)
Root/NN
Mean/JJ
Square/NN
Fluctuation/NN
plot/NN
comparison/NN
of/IN
wild-type/JJ
and/CC
S450L/NN
mutant/JJ
near/JJ
the/DT
binding/NN
site/NN
region/NN
./.
====================
Red/VBN
and/CC
blue/JJ
are/VBP
used/VBN
for/IN
the/DT
wild-type/JJ
and/CC
S450L/NN
mutant/JJ
,/,
respectively/RB
./.
====================
